Mr. Muhammad Saleh Urf Kumail Haider | Optical Fiber Sensors | Young Scientist Award

Mr. Muhammad Saleh Urf Kumail Haider | Optical Fiber Sensors | Young Scientist Award

Mr. Muhammad Saleh Urf Kumail Haider, Chongqing Univeristy, China

Muhammad Saleh Kumail Haider is a passionate researcher specializing in optical fiber sensing and intelligent communication systems. He is currently pursuing his Master’s degree in Electronic Information Engineering at Chongqing University, China, supported by a prestigious CSC fully funded scholarship. With a Bachelor’s degree in Electronic Engineering from the University of Sindh, Pakistan, his academic and research trajectory reflects a deep commitment to innovation in sensor technology. His research experience spans advanced laboratories in China and Pakistan, including work on graphene/silicon sensors and polymer optical fiber (POF) sensors. He has contributed to several high-impact Q1 journals with a focus on portable, AI-based, and smartphone-integrated sensing systems. His notable achievements include the Best Research Award for a graphene-based gas sensor and multiple publications in Scientific Reports, IEEE Sensors Journal, and Sensors and Actuators A. His work bridges cutting-edge photonics with practical applications in liquid level, refractive index, and environmental sensing.

Professional Profile:

GOOGLE SCHOLAR

ORCID

Summary of Suitability: Muhammad Saleh Kumail Haider – Young Scientist Award

Muhammad Saleh Kumail Haider is an emerging talent in the field of electronic and optical sensing technologies, with a growing research portfolio in LiFi communication, optical fiber sensors, and graphene-based gas sensors. Currently pursuing his M.Eng. in Electronic Information Engineering at Chongqing University, China, he has already made impactful contributions through research and innovation at a young age.

🎓 Education

  • 📍 Chongqing University, China
    M.Eng. in Electronic Information Engineering (Sep 2022 – Jul 2025)
    🎯 Grade: 82.9%

  • 📍 University of Sindh, Pakistan
    B.S. in Electronic Engineering (Jan 2018 – Dec 2021)
    🎯 GPA: 3.05/4.00

🧪 Research Experience

  • 🔬 Chongqing University (China)
    Lab of Intelligent LiFi & Optical Fiber Sensors (Jan 2023 – Feb 2025)

  • 🧪 University of Sindh (Pakistan)
    Graphene/Silicon Sensors @ National Centre of Excellence in Analytical Chemistry (Feb 2019 – Dec 2021)

🏆 Honors and Awards

  • 🎓 CSC Fully Funded Master’s Scholarship
    (Sep 2022 – Jul 2025)

  • 🥇 Best Research Award
    Graphene-Based Smart Gas Sensor (Mar 2022)

  • 🚗 1st Position – Smart Electric Military Vehicle Project
    (Dec 2019)

Publication Top Notes:

High-Resolution Portable Dual-Point Liquid Level Measurement System Using POF

Water waves detection by utilizing optical fiber surface microchannel sensor

Smartphone-based optical fiber sensor for refractive index sensing using POF

Simultaneous measurement of liquid level and R.I. sensor using POF based on twisted structure

Portable Optical Fiber Sensor for Continuous Liquid Level Sensing Using Commercially Available POF

Dr. Zhi Cao | Optical Sensing Awards | Best Researcher Award

Dr. Zhi Cao | Optical Sensing Awards | Best Researcher Award

Dr. Zhi Cao, Shenzhen People’s Hospital, China

Dr. Zhi Cao is a Postdoctoral Fellow at the Department of Gastroenterology, Shenzhen People’s Hospital, affiliated with the Second Hospital of Jinan University and the First Affiliated Hospital of Southern University of Science and Technology. His academic journey includes a Ph.D. in Pharmacy from Wuhan University, where he worked under the guidance of Prof. Zilin Chen. Dr. Cao has extensive research experience in the fields of theranostic probe development, targeted protein degradation, and multi-omics in drug discovery. He is particularly focused on the development of NIR-I/II probes for cancer and neuroinflammation diagnosis, as well as designing PROTACs for targeted protein degradation. His work also involves single-cell transcriptomics in pancreatic regeneration, CRISPR-Cas9/CAR-T engineering for immunotherapies, and the pharmacodynamic evaluation of antitumor/anti-inflammatory agents. Throughout his career, Dr. Cao has contributed to several competitive research grants, including projects funded by the National Natural Science Foundation of China and Guangdong Provincial Key R&D Program. He has held various academic positions, including a visiting scholar role at Tokyo Metropolitan University and research assistantships at Guangzhou University of Chinese Medicine and Cleveland Clinic’s Lerner Research Institute. Dr. Cao’s interdisciplinary expertise and contributions continue to push the boundaries of pharmacological research, with a focus on innovative approaches to cancer and immune-related diseases.

Professional Profile:

ORCID

Summary of Suitability for Best Researcher Award – Zhi Cao, Ph.D.

Dr. Zhi Cao is an outstanding candidate for the Best Researcher Award, as evidenced by his academic excellence, research expertise, and notable contributions to the fields of theranostic probe development, targeted protein degradation, and drug discovery. With a Ph.D. in Pharmacy from Wuhan University and a wealth of postdoctoral experience at prestigious institutions such as Shenzhen People’s Hospital, Tokyo Metropolitan University, and Cleveland Clinic, Dr. Cao has demonstrated a commitment to advancing scientific knowledge and practical applications in the healthcare field.

Education 🎓

  • Ph.D. in Pharmacy
    Wuhan University (2018.09 – 2021.06)
    Advisor: Prof. Zilin Chen
  • M.Sc. in Microbial & Biochemical Pharmacy
    South China Normal University (2014.09 – 2017.06)
    Advisor: Prof. Xiaodong Ma
  • B.Sc. in Traditional Chinese Pharmacy
    Hunan University of Chinese Medicine (2010.09 – 2014.06)
    Advisor: Prof. Xiangqian Liu

Work Experience 💼

  • Postdoctoral Fellow
    Shenzhen People’s Hospital (Affiliated Second Hospital of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology) (Nov. 2021 – Present)
    Supervisors: Prof. Lisheng Wang, Prof. Shaohui Tang, Prof. Xiaodong Ma
  • Visiting Scholar
    Tokyo Metropolitan University (JST Sakura Science Exchange Program) (Dec. 2019)
    Advisor: Prof. Uchiyama
  • Research Assistant
    Guangzhou University of Chinese Medicine (July 2017 – Aug. 2018)
  • Joint Training Scholar
    Lerner Research Institute, Cleveland Clinic (Jan. 2016 – Mar. 2017)
    Advisor: Prof. Yong Li

Research Expertise 🔬

  1. Theranostic Probe Development:
    Design and application of NIR-I/II probes for cancer and neuroinflammation diagnosis and mechanistic studies.
  2. Targeted Protein Degradation:
    Design, synthesis, and target identification for PROTACs (Proteolysis-Targeting Chimeras).
  3. Multi-Omics & Drug Discovery:
    • Single-cell transcriptomics in pancreatic regeneration (acute necrotizing pancreatitis)
    • CRISPR-Cas9/CAR-T engineering for immunotherapies
    • Capillary electrophoresis/chromatography-based drug target screening
    • Pharmacodynamic evaluation of antitumor/anti-inflammatory agents

Achievements 🏆

  • National Natural Science Foundation of China (NSFC) Grants:
    1. CAIX-Targeted Hypoxia Imaging in Tumors (82073808, ¥560,000, 2021-2024) – Key Member
    2. Wearable Biosensing for Interstitial Biomarkers (22074113, ¥630,000, 2021-2024) – Key Member
  • Guangdong Provincial Key R&D Program:
    • microRNA-Optimized CAR-T Cell Therapy (2017A030311004, ¥500,000, 2017-2020) – Co-Investigator

Awards & Honors 🥇

  • Key Member of NSFC Grants for cancer imaging and biosensing projects.
  • Co-Investigator for Guangdong Provincial Key R&D Program on CAR-T cell therapy.

Publication Top Notes:

Near‐Infrared Imaging Agent ABSi‐148 Alleviates CA IX‐Mediated Hypoxic Fibrosis in Inflammation‐Cancer Transition

Letrozole‐Based Near‐Infrared Dynamic Imaging Targeting Ductal‐Vascular RhoJ From Pancreatic Intraepithelial Neoplasia to Pancreatic Ductal Adenocarcinoma

Characterization of tumor-associated endothelial cells and the development of a prognostic model in pancreatic ductal adenocarcinoma

Design and synthesis of a novel mitochondria-targeted osteosarcoma theranostic agent based on a PIM1 kinase inhibitor.

Strong hydrophilic monolithic column functionalized with amphiphilic benzyl quinine for capillary electrochromatography and application in pharmaceutical analysis